Erratum: Viologen Dendrimers as Antiviral Agents: The Effect of Charge Number and Distance [Journal of Medicinal Chemistry (2010) 53 (3480) DOI: 10.1021/jm100093p);"viologen"dendrimers as antiviral agents: The effect of charge number and distance

Journal of Medicinal Chemistry

Volumn 53, Issue 9, 2010, Pages 3480-3488

  Asaftei, Simona ^a   De Clercq, Erik ^b  

^a UNIVERSITY OF OSNABRÜCK   (Germany)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; DENDRIMER; NEVIRAPINE; PYRIDINIUM DERIVATIVE; VIOLOGEN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG SELECTIVITY; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLECULE; PUNTA TORO VIRUS; REOVIRUS; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SINDBIS VIRUS; TOROVIRUS; VESICULAR STOMATITIS VIRUS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 77952014136     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm100741h     Document Type: Erratum

References (29)

1. Chen, C. Z. S.; Cooper, S. L. Recent Advances in Antimicrobial Dendrimers Adv. Mater. 2000, 12, 843-846
2. Baba, M.; Pauwels, R.; Balzarini, J.; Amout, J.; Desmyter, J.; De Clercq, E. Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vito Proc. Natl. Acad. Sci. U.S.A. 1988, 85, 6132-6136
3. Boas, U.; Heegaard, M. H. Dendrimers in Drug Research Chem. Soc. Rev. 2004, 33, 43-63
4. Bourne, N.; Stanberry, L. R.; Kern, E. R.; Holan, G.; Matthews, B.; BersteD. I. Dendrimers, a New Class of Candidate Topical Microbicides with Activity against Herpes Simplex Virus Infection Antimicrob. Agents Chemother. 2000, 44, 2471-2474
5. Witvrouw, M; Fikkert, W.; Pluymers, W.; Matthews, B.; Mardel, K.; Schols, D.; Raff, J.; Debyser, Z.; De Clercq, E.; Holan, G.; Pannecouque, C. Polyanionic (i.e., Polysulfonate) Dendrimers Can Inhibit the Replication of Human Immunodeficiency Virus by Interfering with Both Virus Adsorption and Later Steps (Reverse Transcriptase/Integrase) in the Virus Replicative Cycle Mol. Pharmacol. 2000, 58, 1100-1108
6. Witvrouw, M; Weigold, H.; Pannecouque, C.; Schols, D.; De Clercq, E.; Holan, G. Potent anti-HIV (type 1 and type 2) activity of polyoxometalates: Structure-activity relationship and mechanism of action J. Med. Chem. 2000, 43, 778-783
7. ArdoN.; Astruc, D. Molecular trees - from syntheses towards applications Bull. Chim. Soc. Fr. 1995, 132, 875-909
8. Heinen, S.; Meyer, W.; Walder, L. Charge trapping in dendrimers with a viologen skeleton and a radial redox gradient J. Electroanal. Chem. 2001, 498, 34-43
9. Kamogawa, H.; Satoh, S. Organic-Solid Photochromism by Photoreduction Mechanism - Aryl Viologens Embedded in Poly(N -Vinyl-2-Pyrrolidone) J. Polym. Sci., Part A 1988, 26, 653-656
10. Bergbreiter, D. E.; Osburn, P. L.; Liu, Y. S. Tridentate SCS palladium(II) complexes: new, highly stable, recyclable catalysts for the heck reaction J. Am. Chem. Soc. 1999, 121, 9531-9538
11. Bruinink, J.; Kregting, C. G. A.; Ponjee, J. J. Modified Viologens with improved electrochemical properties for display applications J. Electrochem. Soc. 1977, 124, 1854-1856
12. Buhleier, E. W.; Wehner, W.; Vögtle, F. Cascade and nonskid-chain-like syntheses of molecular cavity topologies Synthesis 1978, 155-158
13. Heinen, S.; Walder, L. Generation-dependent intramolecular CT complexation in a dendrimer electron sponge consisting of a viologen skeleton Angew. Chem., Int. Ed. 2000, 39, 806-809
14. Vögtle, F.; Zuber, M.; Lichtenthaler, R. G. Simplified technique for synthesis of 1,3,5-tris(bromomethyl)benzene Chem. Ber. 1973, 106, 717-718
15. Amabilino, D. B.; Ashton, P. R.; Belohradsky, M.; Raymon, F. M.; Stoddart, J. F. The controlled self-assembly of a [3]rotaxane incorporating 3 constitutionally different components Chem. Commun. 1995, 747-750
16. Pauwels, R.; De Clercq, E.; Desmyter, J.; Balzarini, J.; Goubau, P.; Herdewijn., P.; Vanderhaeghe, H.; Vandeputte, M. Sensitive and rapid assay on MT-4 cells for the detection of antiviral compounds against the AIDS virus J. Virol. Methods 1987, 16, 171-185
17. Pannecouque, C.; Daelemans, D.; De Clercq, E. Tetrazolium-based colorimetric assay for the detection of HIV replication inhibitors: revisited 20 years later Nat. Protoc. 2008, 3, 427-434
18. Razinkov, V.; Gazumyan, A.; Nikitenko, G.; Ellestad, G.; Krishnamurthy, G. RFI-641 inhibits entry of respiratory syncytial virus via interactions with fusion protein Chem. Biol. 2001, 8, 645-659
19. Horwitz, J. P.; Chua, J.; Noel, M.; Nucleosides, V. The monomesylates of 1-(2-deoxy-beta- d -lyxofuranosyl) thymine J. Org. Chem. 1964, 29, 2076-2078
20. Miyoshi, I.; Kubonishi, I.; Yoshimoto, S.; Akagi, T.; Ohtsuki, Y.; Nagata, K.; Hinuma, Y. Detection of type C viral particles in a cord T-cell line derived by cocultivation of normal human leukocytes and human leukemic T-cells Nature 1981, 294, 770-771
21. SalahuddS. Z.; Markham, P. D.; Wong-Staal, F.; Franchini, G.; Kalyanaraman, V. S.; Gallo, R. C. Restricted expression of human T-cell leukemia-lymphoma virus (HTLV) in transformed human umbilical cord blood lymphocytes Virology 1983, 129, 51-64
22. Popovic, M.; Sarngadharan, M. G.; Read, E.; Gallo, R. C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS Science 1984, 224, 497-500 (Pubitemid 14134740)
23. Stauber, R. H.; Horie, K.; Carney, P.; Hudson, E. A.; Tarasova, N. I.; Gaitanaris, G. A.; Pavlakis, G. N. Development and applications of enhanced green fluorescent protein mutants BioTechniques 1998, 24, 462-471
24. ValentA.; Lu, W.; Rosati, M.; Schneider, R.; Albert, J.; Karlsson, A.; Pavlakis, G. N. Dual effect of interleukin 4 on HIV-1 expression: implications for viral phenotypic switch and disease progression Proc. Natl. Acad. Sci. U.S.A. 1998, 95, 8886-8891
25. Braaten, D.; Aberham, C.; Franke, E. K.; YL.; Phares, W.; Luban., J. Cyclosporine A-resistant human immunodeficiency virus type 1 mutants demonstrate that Gag encodes the functional target of cyclophilin A J. Virol. 1996, 70, 5170-5176
26. Berthoux, L.; Sebastian, S.; Sokolskaja, E.; Luban, J. Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 14849-14853
27. Zhang, W.; Morris, Q. D.; Chang, R.; Shai, O.; Bakowski, M. A.; Mitsakakis, N.; Mohammad, N.; Robinson, M. D.; Zirngibl, R.; Somogyi, E.; LaurN.; Eftekharpour, E.; Sat, E.; Grigull, J.; Pan, Q.; Peng, W. T.; Krogan, N.; Greenblatt, J.; Fehlings, M.; van der Kooy, D.; AubJ.; Bruneau, B. G.; Rossant, J.; Blencowe, B. J.; Frey, B. J.; Hughes, T. R. The functional landscape of mouse gene expression J. Biol. 2004, 3, 21.1-21.22
28. Daelemans, D.; Pannecouque, C.; Pavlakis, G. N.; Tabarrini, O.; De Clercq, E. A novel and efficient approach to discriminate between pre- and post-transcription HIV inhibitors Mol. Pharmacol. 2005, 67, 1574-1580
29. Pauwels, R.; Andries, K.; Desmyter, J.; Schols, D.; Kukla, M. J.; BreslH. J.; Raeymaeckers, A.; Van Gelder, J.; Woestenborghs, R.; Heykants, J.; Schellekens, K.; Janssen, M. A. C.; De Clercq, E.; Janssen, P. A. J. Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives Nature 1990, 343, 470-474 (Pubitemid 120028562)